Abbott Laboratories | 10-Q: Quarterly report
May 2 16:15 ET
Abbott Laboratories | 8-K: Current report
May 1 16:07 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Stratton John G
Apr 30 18:32 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director STARKS DANIEL J
Apr 30 18:27 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Roman Michael F
Apr 30 18:22 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director O'Grady Michael
Apr 30 18:12 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director McKinstry Nancy
Apr 30 18:07 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director McDew Darren W
Apr 30 18:02 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Kumbier Michelle
Apr 30 17:57 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Gonzalez Patricia Paola
Apr 30 17:52 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Blount Sally E.
Apr 30 17:47 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Babineaux-Fontenot Claire
Apr 30 17:42 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J
Apr 30 17:36 ET
Abbott Laboratories | 8-K: Current report
Apr 29 16:13 ET
Abbott Laboratories | 8-K: Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
Apr 17 07:39 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Stratton John G
Apr 2 19:01 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Roman Michael F
Apr 2 18:55 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Gonzalez Patricia Paola
Apr 2 18:46 ET
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J
Apr 2 18:37 ET
Abbott Laboratories | DEF 14A: Definitive information statements
Mar 15 22:27 ET
No Data
No Data